Diabetes care company Podimetrics scored $45 million in a Series C financing round led by D1 Capital Partners, the Medtech Convergence Fund and an undisclosed strategic investor, Mobi Helath News reports.
Others participating in the round include Polaris Partners and Scientific Health Development. The startup’s product, the FDA-cleared SmartMat, measures the foot temperature of high-risk patients, alerting them to early signs of diabetic foot ulcers.
The capital will be used to expand Podimetrics’ product development and research teams, and to add to the number of services provided by their nurse support teams. Read more.
